Tofacitinib Mitigates the Increased SARS-CoV-2 Infection Susceptibility Caused by an IBD Risk Variant in the PTPN2 Gene

Spalinger; Marianne; Sanati; Golshid; Chatterjee; Pritha; Hai; Rong; Li; Jiang; Santos; Alina N; Nordgren; Tara; Tremblay; Michel L; Eckmann; Lars; Hanson; Elaine

doi:10.5167/uzh-291316

Tofacitinib Mitigates the Increased SARS-CoV-2 Infection Susceptibility Caused by an IBD Risk Variant in the PTPN2 Gene

Identifier:nobleid.org/w1/20260515/40EB1EE0

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/40EB1EE0.svg?ark=w1%2F20260515%2F40EB1EE0)](https://nobleid.org/work/w1/20260515/40EB1EE0)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

Tofacitinib Mitigates the Increased SARS-CoV-2 Infection Susceptibility Caused by an IBD Risk Variant in the PTPN2 Gene

Identifier:nobleid.org/w1/20260515/40EB1EE0

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/40EB1EE0.svg?ark=w1%2F20260515%2F40EB1EE0)](https://nobleid.org/work/w1/20260515/40EB1EE0)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work